Export 4 results:
Author Title Type [ Year(Desc)]
Filters: Author is Fiellin, David A  [Clear All Filters]
2019
G. D'Onofrio, E Edelman, J., Hawk, K. F., Pantalon, M. V., Chawarski, M. C., Owens, P. H., Martel, S. H., VanVeldhuisen, P., Oden, N., Murphy, S. M., Huntley, K., O'Connor, P. G., and Fiellin, D. A., “Implementation facilitation to promote emergency department-initiated buprenorphine for opioid use disorder: protocol for a hybrid type III effectiveness-implementation study (Project ED HEALTH).”, Implement Sci, vol. 14, no. 1, p. 48, 2019.
2020
G. B. Bart, Saxon, A., Fiellin, D. A., McNeely, J., Muench, J. P., Shanahan, C. W., Huntley, K., and Gore-Langton, R. E., “Developing a clinical decision support for opioid use disorders: a NIDA center for the clinical trials network working group report.”, Addict Sci Clin Pract, vol. 15, no. 1, p. 4, 2020.
2021
G. D'Onofrio, Hawk, K. F., Herring, A. A., Perrone, J., Cowan, E., McCormack, R. P., Dziura, J., R Taylor, A., Coupet, E., E Edelman, J., Pantalon, M. V., Owens, P. H., Martel, S. H., O'Connor, P. G., Van Veldhuisen, P., DeVogel, N., Huntley, K., Murphy, S. M., Lofwall, M. R., Walsh, S. L., and Fiellin, D. A., “The design and conduct of a randomized clinical trial comparing emergency department initiation of sublingual versus a 7-day extended-release injection formulation of buprenorphine for opioid use disorder: Project ED Innovation.”, Contemp Clin Trials, vol. 104, p. 106359, 2021.
2023
G. D'Onofrio, E Edelman, J., Hawk, K. F., Chawarski, M. C., Pantalon, M. V., Owens, P. H., Martel, S. H., Rothman, R., Saheed, M., Schwartz, R. P., Cowan, E., Richardson, L., Salsitz, E., Lyons, M. S., Freiermuth, C., Wilder, C., Whiteside, L., Tsui, J. I., Klein, J. W., Coupet, E., O'Connor, P. G., Matthews, A. G., Murphy, S. M., Huntley, K., and Fiellin, D. A., “Implementation Facilitation to Promote Emergency Department-Initiated Buprenorphine for Opioid Use Disorder”, JAMA Netw Open, vol. 6, no. 4, p. e235439, 2023.